Abstracts & Poster Presentations
We’re glad to welcome trainees in the field of theranostics and radiopharmaceuticals to the Leaders’ Summit 2025 as part of our Call for Abstracts. The successful candidates are listed below along with the details of their research.
Mark Macsuka
University of Oxford
Cyclic Changes of Absorbed Dose as a Biomarker for Radiological Response in Neuroendocrine Tumours Treated with [177Lu]Lu-DOTATATE
Michael Valic
UHN/ University of Toronto
Joshua Mojica
Simon Fraser University
Itzel Astiazarán-Rascón
BC Cancer Research Centre/UBC
Scott McNeil
TRIUMF (UBC)
Cyclotron Production of Tb-155
Dominic Simpson
Centre for Addiction and Mental Health (CAMH)
Examination of neuroinflammation in multiple sclerosis mouse models via quantification of cyclooxygenase-1 (COX-1) with the PET radioligand, [¹¹C]PS13.
Chloe Green
McMaster University
Optimization of Technetium-94m Production by Cyclotron Proton Irradiation of Phosphomolybdic Acid using an Automated Liquid Target System
Ibrahim Alrekhais
UHN
Colin Belliveau
University of Montreal
Adaptive External Beam and Radioligand Radiotherapy for MEtaSTatic castration resistant prostate cancer (ARREST) : a phase II registry-based RCT
Desiree Fiaccabrino
On behalf of the Leaders’ Summit Executive Planning Committee, thank you to poster walk professors Dr. Glenn Bauman, London Health Sciences; Dr. David Green, University Health Network; Dr. Cynthia Menard, CHUM; and Dr. Raymond Reilly, University of Toronto.